Previous 10 | Next 10 |
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Short-squeeze stocks are making headlines as the collective action of the Reddit community provides positive momentum for their share prices. However, many dive into these stocks without researching tangible data. Therefore...
SALT LAKE CITY, June 30, 2021 (GLOBE NEWSWIRE) -- Clene Inc. (NASDAQ: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company dedicated to the treatment of cellular energetic fail...
Clene (CLNN) and its wholly owned subsidiary Clene Nanomedicine to join the broad-market Russell 3000 Index and the small-cap Russell 2000 Index at annual reconstitution, effective Monday, June 28, 2021.“Clene is proud to become a member of ...
SALT LAKE CITY, June 28, 2021 (GLOBE NEWSWIRE) -- Clene Inc. (NASDAQ: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company dedicated to the treatment of neurodegenerative disease u...
SALT LAKE CITY, June 15, 2021 (GLOBE NEWSWIRE) -- Clene Inc. (NASDAQ: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company dedicated to the treatment of neurodegenerative disease u...
Insider buying increased last week. Notable Insider Buys: PennyMac Financial Services, Inc., Morphic Holding, Inc., Bumble Inc., Clene Inc., Forum Energy Technologies, Inc. Notable Insider Sells: Walmart Inc., Facebook, Inc., Squarespace, Inc., Sun Communities, Inc., XPEL, Inc. ...
SALT LAKE CITY, May 24, 2021 (GLOBE NEWSWIRE) -- Clene Inc. (NASDAQ: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company dedicated to the treatment of neurodegenerative disease us...
SALT LAKE CITY, May 19, 2021 (GLOBE NEWSWIRE) -- Clene Inc. (NASDAQ: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company dedicated to the treatment of neurodegenerative disease us...
International award will fund preclinical study of CNM-Au8 nanocatalysis for the improvement of human health and lifespan in the contexts of aging and Alzheimer’s disease Clene anticipates the expansion of disease indications for CNM-Au8 beyond amyotrophic lateral s...
Clene (CLNN) posted results from a mid-stage trial, which showed that the company's treatment CNM-Au8 may have the potential for neuro-repair in amyotrophic lateral sclerosis ((ALS)) patients.The Phase 2 RESCUE-ALS trial is evaluating the efficacy, safety, pharmacokinetics, and phar...
News, Short Squeeze, Breakout and More Instantly...
Clene plans to submit a briefing book to the U.S. Food and Drug Administration by July 13 as Part of Overall Process to Support Approval for CNM-Au8(R) for Treatment of ALS Type C interaction is aimed at obtaining FDA feedback on the potential pathway for a new drug application for CNM-Au8 as a...
Latest figures from the World Health Organization show that more than 8.5 million individuals around the globe are living with Parkinson’s disease . This disease is the fastest-growing neurodegenerative disorder globally, with the number of individuals with this illness more than doubli...
A look at the top 10 most actives in the United States Kazia Therapeutics Limited (KZIA) rose 106.5% to $1.38 on volume of 71,739,314 shares Renalytix plc (RNLX) rose 41.4% to $0.4269 on volume of 54,892,134 shares Maxeon Solar Technologies Ltd. (MAXN) fell 7.4% to $0.1951 on volume of 45...